Inspire Medical Systems, Inc.

INSP Healthcare Medical Devices

Inspire Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $912.0 million, up 13.6% from fiscal 2024.

Revenue
−7.93%
EPS
−348.0%
Free cash flow
−33.1%

Quarter to September 2026, against a year earlier

64.22 2.31 −3.47%
Market cap
$1.9B
P/E
19.1×
Fwd P/E
−1,627×
Dividend yield
—
F-score
6/9
Altman Z
14.49
Beneish M
−1.88
Dividend safety
n/a
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

18.37 11.39 9.57 19.95
P/S ratio
2.97 1.62 1.43 2.28
P/FCF ratio
34.52 15.31 10.99 20.50
P/Operating CF
51.62 115.21 55.38 43.22
P/B ratio
3.47 1.87 1.56 2.43
EV/Sales
2.64 1.32 1.09 1.92
EV/EBITDA
38.86 18.45 13.93 50.93
EV/FCF
30.71 12.47 8.33 17.25
Current Ratio
6.08 6.34 8.55 6.45
Net Debt/EBITDA
(6.22) (76.67) (83.38) 13.69
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
5.44% 8.78% 10.45% 5.01%
Free Cash Flow Yield
2.90% 6.53% 9.10% 4.88%
Free Cash Flow per Share
1.42 0.11 0.49 1.34
Book value per Share
26.60 27.61 28.63 28.59
Free Cash Flow
41.81 3.12 14.07 38.88
EV/EBIT
47.30 23.51 18.02 107.11
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026